SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000902664-20-001297
Filing Date
2020-02-21
Accepted
2020-02-21 16:08:29
Documents
1

Document Format Files

Seq Description Document Type Size
1 CELLULAR BIOMEDICINE GROUP, INC. p20-0692sc13da.htm SC 13D/A 75589
  Complete submission text file 0000902664-20-001297.txt   77331
Mailing Address 1345 AVENUE OF THE AMERICAS 11TH FLOOR NEW YORK NY 10105
Business Address 1345 AVENUE OF THE AMERICAS 11TH FLOOR NEW YORK NY 10105 (347) 905 5663
Cellular Biomedicine Group, Inc. (Subject) CIK: 0001378624 (see all company filings)

IRS No.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-82437 | Film No.: 20640081
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O UNIT 2006-08, 20F HARBOUR CENTRE 25 HARBOUR ROAD WAN CHAI K3 00000
Business Address C/O UNIT 2006-08, 20F HARBOUR CENTRE 25 HARBOUR ROAD WAN CHAI K3 00000 85226302000
Sailing Capital Overseas Investments Fund, LP (Filed by) CIK: 0001731251 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D/A